Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OA0H
|
|||
| Former ID |
DIB007203
|
|||
| Drug Name |
INO-3112
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0] | Phase 1/2 | [1] | |
| Head and neck cancer [ICD-11: 2D42] | Phase 1/2 | [2], [3] | ||
| Company |
Inovio pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02172911) A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.